Search Results

Mirtazapine 25 mg  | 99.30%

TargetMol

Mirtazapine is a tetracyclic antidepressant with a somewhat unique mechanism of action. Mirtazapine therapy can be associated with transient asymptomatic elevations in serum aminotransferase levels and has been linked to rare instances of clinically apparent acute liver injury.

More Information Supplier Page

Mirtazapine 100 mg  | 99.30%

TargetMol

Mirtazapine is a tetracyclic antidepressant with a somewhat unique mechanism of action. Mirtazapine therapy can be associated with transient asymptomatic elevations in serum aminotransferase levels and has been linked to rare instances of clinically apparent acute liver injury.

More Information Supplier Page

Mirtazapine 200 mg  | 99.30%

TargetMol

Mirtazapine is a tetracyclic antidepressant with a somewhat unique mechanism of action. Mirtazapine therapy can be associated with transient asymptomatic elevations in serum aminotransferase levels and has been linked to rare instances of clinically apparent acute liver injury.

More Information Supplier Page

Lobeline hydrochloride 200 mg  | 99.65%

TargetMol

Lobeline hydrochloride is a nicotinic receptor agonist, acting as an effective antagonist at both α4β2 and α3β2 neuronal nicotinic receptor subtypes.

More Information Supplier Page

Anastrozole 25 mg  | 99.96%

TargetMol

Anastrozole(ZD1033), a potent and highly selective aromatase (CYP19) inhibitor (IC50 = 15 nM), has no obvious effect on adrenocorticoid hormone synthesis.

More Information Supplier Page

Gluconate Calcium 200 mg  | Purity Not Available

TargetMol

Gluconate Calcium (Gluconic acid hemicalcium salt) is the calcium salt of gluconic acid, used as a calcium replenisher in hypocalcemic states.

More Information Supplier Page

SB 239063 25 mg  | 99.81%

TargetMol

SB239063 is a potent and selective p38 MAPKα/β inhibitor with IC50 of 44 nM, showing no activity against the γ- and δ-kinase isoforms.

More Information Supplier Page

SB 239063 5 mg  | 99.81%

TargetMol

SB239063 is a potent and selective p38 MAPKα/β inhibitor with IC50 of 44 nM, showing no activity against the γ- and δ-kinase isoforms.

More Information Supplier Page